Morocco Pharmaceuticals and Healthcare Report Q1 2016
BMI View: The Moroccan government’s decision to reimburse generic Sovaldi (sofosbuvir) along with the
incorporation of students into it medical coverage scheme highlights its commitment to increasing the
population’s access to healthcare – a positive to drugmakers. However, in the long-term, the uncertainty
surrounding drug prices will still remain an issue for drugmakers, hindering the country’s attractiveness to
drug companies whose portfolios contain high value drugs.
Headline Expenditure Projections
? Pharmaceuticals: MAD12.52bn (USD1.49bn) in 2014 to MAD13.39bn (USD1.40bn) in 2015; +6.8% in
local currency terms and -5.9% in US dollar terms. Forecast revised upwards from last quarter.
? Healthcare: MAD55.63bn (USD6.61bn) in 2014 to MAD59.35bn (USD6.21bn) in 2015; +6.7% in local
currency terms and -6.1% in US dollar terms. Forecast revised downwards from last quarter.
BMI Industry View 7
Table: Headline Pharmaceuticals & Healthcare Forecasts (Morocco 2013-2019) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Morocco 2011-2019) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Morocco 2011-2019) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Morocco 2011-2019) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Morocco 2011-2019) 16
Prescription Drug Market Forecast 17
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Morocco 2011-2019) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Morocco 2011-2019) 22
Generic Drug Market Forecast 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Morocco 2011-2019) 26
OTC Drug Market Forecast 27
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Morocco 2011-2019) 29
Pharmaceutical Trade Forecast 30
Table: Pharmaceutical Trade Data And Forecasts (Morocco 2013-2019) 33
Table: Pharmaceutical Trade Data And Forecasts local currency (Morocco 2013-2019) 33
Pharmaceuticals & Healthcare Risk/Reward Index 34
Middle East and Africa Risk/Reward Index - Q1 2016 34
Morocco Risk/ Reward Index 42
Rewards 42
Risks 43
Market Overview 45
Epidemiology 45
Healthcare Sector 48
Table: Healthcare Resources (Morocco 2009-2014) 52
Table: Healthcare Personnel (Morocco 2009-2014) 53
Table: Healthcare Activity (Morocco 2009-2014) 53
Healthcare Insurance 53
Recent Health Insurance Developments 55
Research & Development 58
Clinical Trials 59
Regulatory Review 60
Intellectual Property Regime 61
Pricing Regime 61
Reimbursement Regime 64
Competitive Landscape 67
Pharmaceutical Industry 67
Table: Morocco's Select Pharmaceutical Industry Indicators 67
Table: Members Of MIS, 2011 68
Table: Members Of AMIP, 2011 69
Domestic Pharmaceutical sector 69
Foreign Pharmaceutical Companies 70
Table: Multinational Market Activity 73
Pharmaceutical Wholesale 73
Pharmaceutical Retail 74
Company Profile 76
GlaxoSmithKline 76
Laprophan 78
Pfizer 81
Sanofi 84
Sothema 88
Demographic Forecast 91
Demographic Outlook 91
Table: Population Headline Indicators (Morocco 1990-2025) 92
Table: Key Population Ratios (Morocco 1990-2025) 92
Table: Urban/Rural Population & Life Expectancy (Morocco 1990-2025) 93
Table: Population By Age Group (Morocco 1990-2025) 93
Table: Population By Age Group % (Morocco 1990-2025) 94
Glossary 96
Methodology 98
Pharmaceutical Expenditure Forecast Model 98
Healthcare Expenditure Forecast Model 98
Notes On Methodology 99
Risk/Reward Index Methodology 100
Index Overview 101
Table: Pharmaceutical Risk/Reward Index Indicators 101
Indicator Weightings 102
List of Tables
Table: Headline Pharmaceuticals & Healthcare Forecasts (Morocco 2013-2019)
Table: Pharmaceutical Sales, Historical Data And Forecasts (Morocco 2011-2019)
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Morocco 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Morocco 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Morocco 2011-2019)
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Morocco 2011-2019)
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Morocco 2011-2019)
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Morocco 2011-2019)
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Morocco 2011-2019)
Table: Pharmaceutical Trade Data And Forecasts (Morocco 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Morocco 2013-2019)
Table: Healthcare Resources (Morocco 2009-2014)
Table: Healthcare Personnel (Morocco 2009-2014)
Table: Healthcare Activity (Morocco 2009-2014)
Table: Morocco's Select Pharmaceutical Industry Indicators
Table: Members Of MIS, 2011
Table: Members Of AMIP, 2011
Table: Multinational Market Activity
Table: Population Headline Indicators (Morocco 1990-2025)
Table: Key Population Ratios (Morocco 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Morocco 1990-2025)
Table: Population By Age Group (Morocco 1990-2025)
Table: Population By Age Group % (Morocco 1990-2025)
Table: Pharmaceutical Risk/Reward Index Indicators